The upregulation of IGFBP4 (encodes for a protein that binds insulin-like growth factors I and II26), was shown to function as a potent tumor suppressor in hepatocellular carcinoma and delay tumor formation in prostate cancer cells41,42. This evidence concerns the gene IGF1 and hepatocellular carcinoma.